Dean Foundation for Health, Research, and Education

Middleton, Wisconsin 53562

0 studies enrolling now · 10 studies all time

What they study most

ADHD Specifically With Executive Function Impairment, Adult Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, Chronic Migraine, Major Depressive Disorder, Migraine, Migraine Headache, Smoking Cessation

Studies at this site

• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Smoking Cessation Study In Healthy Adolescent Smokers — Completed
• Dasotraline Adult ADHD Study — Completed
• Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil — Stopped early